gdc

Breast Cancer

Articles and resources on breast cancer for patients, caregivers, and family members
My Family's Love is the Reason I Fight
Breast CancerSurvivorshipWeb Exclusives
Melody recounts her story of being a 34-year-old new mother diagnosed with breast cancer.
A Young Survivor of Triple-Negative Breast Cancer
Breast CancerPatient Stories
With an infant son and a difficult-to-treat breast cancer, Sal Gregory decided she had to gather strength through her faith and positive attitude.
First Immunotherapy Approved for Patients with Advanced or Metastatic Triple-Negative Breast Cancer Expressing PD-L1
Breast CancerFDA Approvals, News & UpdatesImmunotherapy
In March 2019, the FDA approved Tecentriq (atezolizumab), a PD-L1 inhibitor, in combination with Abraxane (paclitaxel protein-bound), for use in adults with locally advanced or metastatic triple-negative breast cancer whose tumors cannot be removed by surgery and express PD-L1, as identified by an FDA-approved test. This is the first FDA-approved immunotherapy for patients with advanced or metastatic triple-negative breast cancer.
You Never Think It Will Happen to You
Breast CancerPatient Stories
Regina Groce, a young wife and mother, thought her life was everything it was supposed to be, until a devastating phone call after surgery to remove a lump in her breast revealed she was carrying the BRCA mutation.
Page 1 of 7
Results 1 - 10 of 69

Subscribe to CONQUER: the patient voice® magazine

Receive timely cancer news & updates, patient stories, and more.

Country